BRPI0813725A2 - Métodos e composições para tratamento de doenças - Google Patents
Métodos e composições para tratamento de doençasInfo
- Publication number
- BRPI0813725A2 BRPI0813725A2 BRPI0813725-0A2A BRPI0813725A BRPI0813725A2 BR PI0813725 A2 BRPI0813725 A2 BR PI0813725A2 BR PI0813725 A BRPI0813725 A BR PI0813725A BR PI0813725 A2 BRPI0813725 A2 BR PI0813725A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- disease treatment
- disease
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94520507P | 2007-06-20 | 2007-06-20 | |
PCT/EP2008/057731 WO2008155365A1 (en) | 2007-06-20 | 2008-06-18 | Methods and compositions for treating allergic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0813725A2 true BRPI0813725A2 (pt) | 2014-12-30 |
Family
ID=39846944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0813725-0A2A BRPI0813725A2 (pt) | 2007-06-20 | 2008-06-18 | Métodos e composições para tratamento de doenças |
Country Status (20)
Country | Link |
---|---|
US (1) | US8101182B2 (pt) |
EP (1) | EP2170957A1 (pt) |
JP (1) | JP2010530233A (pt) |
KR (1) | KR20100034015A (pt) |
CN (1) | CN102027012A (pt) |
AR (1) | AR067045A1 (pt) |
AU (1) | AU2008265128A1 (pt) |
BR (1) | BRPI0813725A2 (pt) |
CA (1) | CA2691157A1 (pt) |
CL (1) | CL2008001826A1 (pt) |
CO (1) | CO6251325A2 (pt) |
CR (1) | CR11152A (pt) |
EA (1) | EA201000006A1 (pt) |
EC (1) | ECSP099812A (pt) |
IL (1) | IL202573A0 (pt) |
PE (1) | PE20090768A1 (pt) |
TN (1) | TN2009000529A1 (pt) |
TW (1) | TW200918557A (pt) |
WO (1) | WO2008155365A1 (pt) |
ZA (1) | ZA200908711B (pt) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE362534T2 (de) | 1998-11-13 | 2007-06-15 | Immunex Corp | Menschliche tslp nukleinsäuren und polypeptide |
MXPA04000631A (es) | 2001-07-23 | 2004-06-25 | Immunex Corp | Linfopoyetina timica estromatica humana modificada. |
AU2008287426B2 (en) * | 2007-08-10 | 2014-06-26 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
US8470966B2 (en) | 2007-08-10 | 2013-06-25 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
US8680019B2 (en) * | 2007-08-10 | 2014-03-25 | Protelica, Inc. | Universal fibronectin Type III binding-domain libraries |
US7982016B2 (en) | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
US8475793B2 (en) | 2008-02-07 | 2013-07-02 | Merck Sharp & Dohme Corp. | Engineered anti-TSLPR antibodies |
AR082163A1 (es) * | 2010-07-15 | 2012-11-14 | Hoffmann La Roche | Anticuerpos especificamente ligantes del tslpr humano y metodos de utilizacion de los mismos |
KR101221649B1 (ko) * | 2010-11-01 | 2013-01-14 | 광주과학기술원 | 알러지 질환의 예방 또는 치료용 약제학적 조성물, 그의 스크리닝 방법 |
WO2015020193A1 (ja) | 2013-08-09 | 2015-02-12 | アステラス製薬株式会社 | 新規抗ヒトtslp受容体抗体 |
KR102496507B1 (ko) | 2014-05-07 | 2023-02-03 | 암겐 인코포레이티드 | 충격 감소 요소들을 가진 자동 주사기 |
JP6671298B2 (ja) | 2014-05-16 | 2020-03-25 | アムジェン インコーポレイテッド | Th1及びth2細胞集団を検出するためのアッセイ |
WO2015187793A1 (en) | 2014-06-03 | 2015-12-10 | Amgen Inc. | Drug delivery system and method of use |
MX2021014323A (es) | 2014-10-14 | 2023-02-02 | Amgen Inc | Dispositivo de inyección de fármaco con indicadores visuales y audibles. |
MX2017005243A (es) | 2014-10-23 | 2017-08-18 | Amgen Inc | Reducción de la viscosidad de formulaciones farmacéuticas. |
US11357916B2 (en) | 2014-12-19 | 2022-06-14 | Amgen Inc. | Drug delivery device with live button or user interface field |
WO2016133947A1 (en) | 2015-02-17 | 2016-08-25 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
EP3261690B1 (en) | 2015-02-27 | 2021-12-15 | Amgen Inc. | Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement |
WO2017039786A1 (en) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Syringe assembly adapter for a syringe |
BR112018003326A2 (pt) | 2015-09-09 | 2018-09-18 | Novartis Ag | anticorpos de ligação de linfopoietina estromal tímica (tslp) e métodos de uso dos anticorpos |
AU2016320748B2 (en) | 2015-09-09 | 2019-05-02 | Novartis Ag | Thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of using the antibodies |
ES2755717T3 (es) | 2015-12-09 | 2020-04-23 | Amgen Inc | Autoinyector con tapa de señalización |
CN108430507B (zh) | 2015-12-18 | 2022-08-02 | 安斯泰来制药株式会社 | 含有抗人tslp受体抗体的药物组合物 |
WO2017120178A1 (en) | 2016-01-06 | 2017-07-13 | Amgen Inc. | Auto-injector with signaling electronics |
EP4035711A1 (en) | 2016-03-15 | 2022-08-03 | Amgen Inc. | Reducing probability of glass breakage in drug delivery devices |
WO2017189089A1 (en) | 2016-04-29 | 2017-11-02 | Amgen Inc. | Drug delivery device with messaging label |
WO2017192287A1 (en) | 2016-05-02 | 2017-11-09 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
MX2018013616A (es) | 2016-05-13 | 2019-02-21 | Amgen Inc | Montaje de cubierta protectora de vial. |
EP3458988B1 (en) | 2016-05-16 | 2023-10-18 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
WO2017209899A1 (en) | 2016-06-03 | 2017-12-07 | Amgen Inc. | Impact testing apparatuses and methods for drug delivery devices |
EP3478342A1 (en) | 2016-07-01 | 2019-05-08 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
WO2018034784A1 (en) | 2016-08-17 | 2018-02-22 | Amgen Inc. | Drug delivery device with placement detection |
EP3532127A1 (en) | 2016-10-25 | 2019-09-04 | Amgen Inc. | On-body injector |
US20190358411A1 (en) | 2017-01-17 | 2019-11-28 | Amgen Inc. | Injection devices and related methods of use and assembly |
EP3582825A1 (en) | 2017-02-17 | 2019-12-25 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
AU2018221351B2 (en) | 2017-02-17 | 2023-02-23 | Amgen Inc. | Insertion mechanism for drug delivery device |
MX2019010544A (es) | 2017-03-06 | 2019-10-21 | Amgen Inc | Dispositivo de administracion de farmacos con caracteristica de prevencion de la activacion. |
SG11201908058UA (en) | 2017-03-07 | 2019-09-27 | Amgen Inc | Needle insertion by overpressure |
KR20240005194A (ko) | 2017-03-09 | 2024-01-11 | 암겐 인코포레이티드 | 약물 전달 장치용 삽입 메커니즘 |
CA3052676A1 (en) | 2017-03-28 | 2018-10-04 | Amgen Inc. | Plunger rod and syringe assembly system and method |
CA3059369A1 (en) | 2017-04-28 | 2018-11-01 | Amgen Inc. | N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides |
AU2018280054B2 (en) | 2017-06-08 | 2023-07-13 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
US11904143B2 (en) | 2017-06-08 | 2024-02-20 | Amgen Inc. | Torque driven drug delivery device |
US11541183B2 (en) | 2017-06-22 | 2023-01-03 | Amgen Inc. | Device activation impact/shock reduction |
MX2019015479A (es) | 2017-06-23 | 2020-02-20 | Amgen Inc | Dispositivo electronico de administracion de farmacos con tapa accionada por un conjunto de conmutador. |
MA49562A (fr) | 2017-07-14 | 2020-05-20 | Amgen Inc | Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion |
JP2020527376A (ja) | 2017-07-21 | 2020-09-10 | アムジエン・インコーポレーテツド | 薬物容器のためのガス透過性シーリング部材及び組立方法 |
WO2019022950A1 (en) | 2017-07-25 | 2019-01-31 | Amgen Inc. | DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF |
MA49677A (fr) | 2017-07-25 | 2021-04-21 | Amgen Inc | Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé |
MA49757A (fr) | 2017-08-01 | 2020-06-10 | Amgen Inc | Systèmes et procédés de préparation en temps réel d'un échantillon de polypeptide pour analyse par spectrométrie de masse |
WO2019028191A1 (en) | 2017-08-01 | 2019-02-07 | Amgen Inc. | SYSTEMS AND METHODS FOR PERFORMING REAL-TIME GLYCAN ASSAY OF A SAMPLE |
WO2019032482A2 (en) | 2017-08-09 | 2019-02-14 | Amgen Inc. | HYDRAULIC-PNEUMATIC PRESSURE CHAMBER DELIVERY SYSTEM |
EP3668567A1 (en) | 2017-08-18 | 2020-06-24 | Amgen Inc. | Wearable injector with sterile adhesive patch |
US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
ES2939292T3 (es) | 2017-10-04 | 2023-04-20 | Amgen Inc | Adaptador de flujo para dispositivo de administración de fármacos |
MA50614A (fr) | 2017-10-06 | 2020-08-12 | Amgen Inc | Dispositif d'administration de médicament comprenant un ensemble de verrouillage et procédé d'assemblage associé |
WO2019074579A1 (en) | 2017-10-09 | 2019-04-18 | Amgen Inc. | DRUG DELIVERY DEVICE COMPRISING A DRIVE ASSEMBLY AND ASSEMBLY METHOD THEREOF |
WO2019090079A1 (en) | 2017-11-03 | 2019-05-09 | Amgen Inc. | System and approaches for sterilizing a drug delivery device |
MA50553A (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc | Dispositif d'administration de médicament avec détection de positionnement et de débit |
EP3707075A1 (en) | 2017-11-06 | 2020-09-16 | Amgen Inc. | Fill-finish assemblies and related methods |
WO2019094138A1 (en) | 2017-11-10 | 2019-05-16 | Amgen Inc. | Plungers for drug delivery devices |
MA50904A (fr) | 2017-11-16 | 2020-09-23 | Amgen Inc | Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament |
MA52015A (fr) | 2018-03-13 | 2021-01-20 | Amgen Inc | Digestion séquentielle de polypeptides pour une analyse par spectrométrie de masse |
ES2965064T3 (es) | 2018-03-13 | 2024-04-10 | Amgen Inc | Métodos para la preparación de polipéptidos resistentes a tripsina para análisis espectrométrico de masas |
US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
KR20200004573A (ko) * | 2018-07-04 | 2020-01-14 | 고려대학교 세종산학협력단 | 옥사졸로퀴놀리논 유도체를 유효성분으로 포함하는 우울증 및 스트레스 관련 질환의 예방 또는 치료용 약학 조성물 |
CA3103681A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Delivery devices for administering drugs |
WO2020023220A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation |
WO2020023336A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with grip portion |
EP3826699A1 (en) | 2018-07-24 | 2021-06-02 | Amgen Inc. | Delivery devices for administering drugs |
CA3103105A1 (en) | 2018-07-31 | 2020-02-06 | Amgen Inc. | Fluid path assembly for a drug delivery device |
CA3106452A1 (en) | 2018-09-24 | 2020-04-02 | Amgen Inc. | Interventional dosing systems and methods |
IL281469B1 (en) | 2018-09-28 | 2024-04-01 | Amgen Inc | Assembling a memory alloy ejector activation assembly for a drug delivery device |
JP2022503983A (ja) | 2018-10-02 | 2022-01-12 | アムジエン・インコーポレーテツド | 内力伝達を伴う薬物送達用の注入システム |
CA3112214A1 (en) | 2018-10-05 | 2020-04-09 | Amgen Inc. | Drug delivery device having dose indicator |
US20210346596A1 (en) | 2018-10-15 | 2021-11-11 | Amgen Inc. | Platform assembly process for drug delivery device |
CA3112355A1 (en) | 2018-10-15 | 2020-04-23 | Amgen Inc. | Drug delivery device having damping mechanism |
US11213620B2 (en) | 2018-11-01 | 2022-01-04 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
WO2020092056A1 (en) | 2018-11-01 | 2020-05-07 | Amgen Inc. | Drug delivery devices with partial needle retraction |
AU2019370159A1 (en) | 2018-11-01 | 2021-04-22 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
AU2019396614A1 (en) | 2018-12-14 | 2021-06-17 | Amgen Inc. | System suitability method for use with protein concentration determination by slope |
US20220137061A1 (en) | 2019-02-14 | 2022-05-05 | Amgen Inc. | Systems And Methods For Preparing A Sample and Performing A Real-Time Assay Of The Sample |
US20220137010A1 (en) | 2019-02-20 | 2022-05-05 | Amgen Inc. | Methods of determining protein stability |
EP3935396A1 (en) | 2019-03-04 | 2022-01-12 | Amgen Inc. | In vivo reversibility of high molecular weight species |
EP3948242A1 (en) | 2019-03-27 | 2022-02-09 | Amgen Inc. | Methods of fingerprinting therapeutic proteins via a two-dimensional (2d) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products |
WO2020219482A1 (en) | 2019-04-24 | 2020-10-29 | Amgen Inc. | Syringe sterilization verification assemblies and methods |
KR20220016897A (ko) | 2019-06-04 | 2022-02-10 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 흉선 기질 림포포이에틴에 결합할 수 있는 항체 및 이의 용도 |
EP3980786A1 (en) | 2019-06-05 | 2022-04-13 | Amgen Inc. | Methods of identifying attributes of therapeutic proteins |
JP2022545227A (ja) | 2019-08-23 | 2022-10-26 | アムジエン・インコーポレーテツド | 構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法 |
CN111171150B (zh) * | 2020-02-05 | 2020-12-08 | 北京智仁美博生物科技有限公司 | 抗人tslp抗体及其用途 |
WO2022061092A1 (en) | 2020-09-18 | 2022-03-24 | Amgen Inc. | Methods of processing a sample for peptide mapping analysis |
MX2023005320A (es) | 2020-11-05 | 2023-05-19 | Amgen Inc | Materiales y metodos para el procesamiento de proteinas. |
IL307418A (en) | 2021-05-21 | 2023-12-01 | Amgen Inc | A method for optimizing a filling recipe for a drug container |
TW202325853A (zh) | 2021-11-09 | 2023-07-01 | 美商安進公司 | 治療性蛋白之生產 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE490980T1 (de) | 1998-03-19 | 2010-12-15 | Human Genome Sciences | Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor |
AU2001271624A1 (en) | 2000-06-28 | 2002-01-08 | Whitehead Institute For Biomedical Research | Thymic stromal lymphopoietin receptor molecules and uses thereof |
ATE419351T1 (de) * | 2000-06-28 | 2009-01-15 | Amgen Inc | Thymus-stroma lymphopoietin rezeptor-moleküle und deren verwendung |
US6890734B2 (en) * | 2000-11-10 | 2005-05-10 | Schering Corporation | Nucleic acids encoding a cytokine receptor complex |
CA2474011C (en) * | 2002-02-01 | 2014-03-25 | Schering Corporation | Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders |
ATE407691T1 (de) * | 2003-07-18 | 2008-09-15 | Schering Corp | Behandlung und diagnose von neoplasien mit tslp (thymic stromal lymphopoietin) |
US20050249712A1 (en) * | 2004-03-23 | 2005-11-10 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Methods for use of TSLP and agonists and antagonists thereof |
US20060039910A1 (en) * | 2004-08-20 | 2006-02-23 | Amgen Inc. | Methods and compositions for treating allergic inflammation |
US20060171943A1 (en) * | 2005-02-01 | 2006-08-03 | Amgen Inc. | Compositions and methods of treating fibrotic disorders |
EP2287196A3 (en) * | 2006-01-13 | 2011-05-04 | Irm Llc | Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases |
US8475793B2 (en) | 2008-02-07 | 2013-07-02 | Merck Sharp & Dohme Corp. | Engineered anti-TSLPR antibodies |
-
2008
- 2008-06-18 JP JP2010512681A patent/JP2010530233A/ja active Pending
- 2008-06-18 AU AU2008265128A patent/AU2008265128A1/en not_active Abandoned
- 2008-06-18 BR BRPI0813725-0A2A patent/BRPI0813725A2/pt not_active IP Right Cessation
- 2008-06-18 KR KR1020107001185A patent/KR20100034015A/ko not_active Application Discontinuation
- 2008-06-18 CA CA2691157A patent/CA2691157A1/en not_active Abandoned
- 2008-06-18 AR ARP080102594A patent/AR067045A1/es not_active Application Discontinuation
- 2008-06-18 WO PCT/EP2008/057731 patent/WO2008155365A1/en active Application Filing
- 2008-06-18 EA EA201000006A patent/EA201000006A1/ru unknown
- 2008-06-18 EP EP08761179A patent/EP2170957A1/en not_active Withdrawn
- 2008-06-18 CN CN2008801025460A patent/CN102027012A/zh active Pending
- 2008-06-18 US US12/141,516 patent/US8101182B2/en not_active Expired - Fee Related
- 2008-06-18 PE PE2008001045A patent/PE20090768A1/es not_active Application Discontinuation
- 2008-06-19 TW TW097122910A patent/TW200918557A/zh unknown
- 2008-06-19 CL CL2008001826A patent/CL2008001826A1/es unknown
-
2009
- 2009-12-07 IL IL202573A patent/IL202573A0/en unknown
- 2009-12-08 ZA ZA200908711A patent/ZA200908711B/xx unknown
- 2009-12-09 CR CR11152A patent/CR11152A/es not_active Application Discontinuation
- 2009-12-17 CO CO09144825A patent/CO6251325A2/es not_active Application Discontinuation
- 2009-12-17 TN TNP2009000529A patent/TN2009000529A1/fr unknown
- 2009-12-18 EC EC2009009812A patent/ECSP099812A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN102027012A (zh) | 2011-04-20 |
EA201000006A1 (ru) | 2010-10-29 |
KR20100034015A (ko) | 2010-03-31 |
TN2009000529A1 (en) | 2011-03-31 |
CL2008001826A1 (es) | 2009-02-20 |
WO2008155365A1 (en) | 2008-12-24 |
AU2008265128A1 (en) | 2008-12-24 |
AR067045A1 (es) | 2009-09-30 |
US20090074747A1 (en) | 2009-03-19 |
CR11152A (es) | 2010-01-20 |
JP2010530233A (ja) | 2010-09-09 |
PE20090768A1 (es) | 2009-07-09 |
IL202573A0 (en) | 2011-08-01 |
ZA200908711B (en) | 2010-08-25 |
CO6251325A2 (es) | 2011-02-21 |
CA2691157A1 (en) | 2008-12-24 |
TW200918557A (en) | 2009-05-01 |
EP2170957A1 (en) | 2010-04-07 |
ECSP099812A (es) | 2010-01-29 |
US8101182B2 (en) | 2012-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
BRPI0922122A2 (pt) | composições e métodos para tratamento de doença celíaca. | |
BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
BRPI0813212A2 (pt) | Métodos de tratamento de doenças e distúrbios mediados por serotonina | |
BRPI0911757A2 (pt) | composiÇÕes e mÉtodos para tratar distérbios digestivos. | |
BRPI0906746A2 (pt) | Aparelho para tratamento de doença de refluxo gastresofágico | |
BR112012004979A2 (pt) | composições para o tratamento de semente e métodos | |
BRPI0807918A2 (pt) | composições e método para preservação de tecido | |
BRPI0909780A2 (pt) | Composições e métodos para liberação de fármaco | |
BRPI0813352A2 (pt) | Composições de fragmento de tecido para o tratamento de incontinência | |
BRPI0810525A2 (pt) | Composições e métodos para a profilaxia e tratamento de dependência química | |
BRPI1008566A2 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
BRPI1009920A2 (pt) | composições bacterianas para profilaxina e tratamento de doença degenerativa. | |
BRPI0822349A2 (pt) | composições e métodos para tratar doenças lisossômicas | |
BRPI0921237A2 (pt) | métodos e composições para o tratamento de distúrbios associados ao complemento | |
BRPI0811589A2 (pt) | Composição farmacêutica e método para tratar câncer | |
BRPI0909164A2 (pt) | método e composições para o tratamento de câncer | |
BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
BRPI0921959A2 (pt) | métodos e composições para remoção de tatuagem | |
BRPI1007600A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
BRPI0813670A2 (pt) | Compostos para tratamento | |
BRPI1007929A2 (pt) | "métodos e composições para o tratamento de neovascularização". | |
BRPI0820885A2 (pt) | Composições e métodos para diagnóstico precoce de gravidez |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |